Trust: The Competitive Advantage Behind Better Oncology Research

By Inga Rose, Founder and CEO

‍

Every company wants to be trusted. Every company says it values trust. Yet trust remains one of the few competitive advantages that can't be bought, copied, or manufactured.

In oncology research, that's especially true.

Patients trust that the specimens they donate will be handled with care and respect. Researchers trust their biospecimen partners to preserve quality, communicate openly, and deliver reliable results. Scientific discovery depends on those relationships, and relationships like those are built over time through consistency, transparency, and accountability - not promises.

Lately, we've been thinking about trust a lot at Reference Medicine. As we've prepared for CAP accreditation, we've spent months examining our quality systems, documentation, and day-to-day operations. While the process focuses on technical standards, it's also reinforced something we've believed from the beginning: trust isn't a byproduct of quality. Quality is one of the ways trust is earned.

Trust Requires Investment

Trust isn't built through good intentions. It's built through choices—and those choices often require an investment. Sometimes the investment is financial. Sometimes it's time. Sometimes it's having a difficult conversation or holding yourself to a higher standard than anyone expects. 

The decisions that earn trust are rarely the easiest ones. They happen when you already know the right thing to do and have to decide whether you're willing to accept the cost.

Do we openly explain a problem, even if it means refunding a project? Do we invest in additional quality controls before they're required? Do we spend months pursuing an accreditation we don't need because we believe it will make us better?

Those decisions aren't really about compliance. They're investments in trust.

CAP accreditation is another example of that philosophy. No one requires us to pursue it. It takes significant time, resources, and scrutiny. But we're investing in it because we believe stronger systems lead to better science—and better science earns greater trust from the researchers and patients who depend on us.

Trust Honors the Person Behind Every Specimen

Every specimen that arrives in our laboratory represents a person who chose to contribute to research in the hope of improving care for someone they'll probably never meet.

That's one reason the research community continues to reflect on the legacy of Henrietta Lacks. Her story changed conversations around informed consent, patient rights, and transparency, reminding us that scientific progress and human dignity have always belonged in the same conversation.

That perspective shapes how we approach our work every day. Quality systems matter because people matter. Documentation matters because stewardship matters. Behind every specimen is someone who placed their trust in the research process. Behind every project are researchers working to answer questions that could improve people’s lives.

When we remember that, quality stops being a checklist and becomes a responsibility.

Earning Trust Every Day

Trust rarely comes from one defining moment. It's built through hundreds of ordinary decisions that, taken together, define who an organization is.

A difficult phone call with a customer doesn't build trust by itself. Neither does an additional quality check or a new accreditation. Any one of those actions might seem small.

Together, though, they send a consistent message: we'll do the right thing even when it's inconvenient, we'll invest in quality before we're asked to, and we'll never lose sight of the people who make this work possible.

That's why we believe trust is a competitive advantage. Organizations that consistently earn trust become the partners researchers return to. They become the laboratories people rely on when the work matters most.

In the end, trust isn't measured by what we say about ourselves. It's measured by the decisions we make when no one is watching.

‍